Rank;Global Rank;Institution;Country;Sector
1;201;Novo Nordisk A/S;DNK;Companies;
2;238;AstraZeneca, United Kingdom;GBR;Companies;
3;260;Novartis Institutes for Biomedical Research, Switzerland;CHE;Companies;
4;264;Philips Research, Eindhoven;NLD;Companies;
5;265;Hoffmann-La Roche, GmbH., Germany;DEU;Companies;
6;305;AstraZeneca, Sweden;SWE;Companies;
7;326;Merck KGaA, Germany;DEU;Companies;
8;346;Bayer AG, Germany;DEU;Companies;
9;494;Hoffmann-La Roche Ltd, Switzerland;CHE;Companies;
10;500;Boehringer Ingelheim GmbH Germany;DEU;Companies;
11;526;Janssen Research & Development, LLC;BEL;Companies;
12;567;IMEC International;BEL;Companies;
13;625;Sanofi, France;FRA;Companies;
14;640;GlaxoSmithKline, United Kingdom;GBR;Companies;
15;778;Pfizer Inc, Spain;ESP;Companies;
16;804;Nestle Switzerland;CHE;Companies;
17;822;VTT Technical Research Centre of Finland;FIN;Companies;
18;829;Novartis, Switzerland;CHE;Companies;
19;872;BASF, Germany;DEU;Companies;
20;1316;UCB Pharma SA, Belgium;BEL;Companies;
21;1334;Bosch, Germany;DEU;Companies;
22;1419;Siemens AG, Germany;DEU;Companies;
23;1740;GlaxoSmithKline, Belgium;BEL;Companies;
24;2031;Syngenta, United Kingdom;GBR;Companies;
25;2045;SINTEF Group *;NOR;Companies;
26;2102;Siemens Healthineers, Germany;DEU;Companies;
27;3015;European XFEL GmbH;DEU;Companies;
28;3495;Sincrotrone Trieste;ITA;Companies;